Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations (vol 78, pg 65, 2018)

被引：3
|
作者：
Zhanel, George G. [1 ,4 ]
Lawrence, Courtney K. [2 ]
Adam, Heather [1 ,6 ]
Schweizer, Frank [1 ,3 ]
Zelenitsky, Sheryl [2 ]
Zhanel, Michael [1 ]
Lagace-Wiens, Philippe R. S. [1 ,6 ]
Walkty, Andrew [1 ,4 ,6 ]
Denisuik, Andrew [1 ]
Golden, Alyssa [1 ]
Gin, Alfred S. [1 ,2 ,5 ]
Hoban, Daryl J. [1 ,6 ]
Lynch, Joseph P., III [7 ]
Karlowsky, James A. [1 ,6 ]
机构：
[1] Univ Manitoba, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada
[2] Univ Manitoba, Coll Pharm, Winnipeg, MB, Canada
[3] Univ Manitoba, Fac Sci, Dept Chem, Winnipeg, MB, Canada
[4] Winnipeg Hlth Sci Ctr, Dept Med, MS673-820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada
[5] Winnipeg Hlth Sci Ctr, Dept Pharm, Winnipeg, MB, Canada
[6] Diagnost Serv Manitoba, Winnipeg, MB, Canada
[7] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm Crit Care Allergy & Clin Immunol, Los Angeles, CA 90095 USA
来源：
DRUGS | 2018年 / 78卷 / 07期
关键词：
D O I：
10.1007/s40265-018-0910-x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Section heading 5.2, which currently reads 5.2 Meropenem-Relebactam.
引用
收藏
页码：787 / 787
页数：1
相关论文
共 17 条
  • [1] Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
    Zhanel, George G.
    Lawrence, Courtney K.
    Adam, Heather
    Schweizer, Frank
    Zelenitsky, Sheryl
    Zhanel, Michael
    Lagace-Wiens, Philippe R. S.
    Walkty, Andrew
    Denisuik, Andrew
    Golden, Alyssa
    Gin, Alfred S.
    Hoban, Daryl J.
    Lynch, Joseph P., III
    Karlowsky, James A.
    DRUGS, 2018, 78 (01) : 65 - 98
  • [2] Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
    George G. Zhanel
    Courtney K. Lawrence
    Heather Adam
    Frank Schweizer
    Sheryl Zelenitsky
    Michael Zhanel
    Philippe R. S. Lagacé-Wiens
    Andrew Walkty
    Andrew Denisuik
    Alyssa Golden
    Alfred S. Gin
    Daryl J. Hoban
    Joseph P. Lynch
    James A. Karlowsky
    Drugs, 2018, 78 : 65 - 98
  • [3] Correction to: Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
    George G. Zhanel
    Courtney K. Lawrence
    Heather Adam
    Frank Schweizer
    Sheryl Zelenitsky
    Michael Zhanel
    Philippe R. S. Lagacé-Wiens
    Andrew Walkty
    Andrew Denisuik
    Alyssa Golden
    Alfred S. Gin
    Daryl J. Hoban
    Joseph P. Lynch
    James A. Karlowsky
    Drugs, 2018, 78 : 787 - 787
  • [4] Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens
    Biagi, M.
    Shajee, A.
    Vialichka, A.
    Jurkovic, M.
    Tan, X.
    Wenzler, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
  • [5] Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
    Patrice Nordmann
    Maxime Bouvier
    Laurent Poirel
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 1145 - 1152
  • [6] Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
    Nordmann, Patrice
    Bouvier, Maxime
    Poirel, Laurent
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (09) : 1145 - 1152
  • [7] In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
    Bonnin, Remy A.
    Bernabeu, Sandrine
    Emeraud, Cecile
    Naas, Thierry
    Girlich, Delphine
    Jousset, Agnes B.
    Dortet, Laurent
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [8] Efficacy and safety of novel carbapenem-β-lactamase inhibitor combinations: imipenem-cilastatin/relebactam results from randomized controlled trials
    Yang, Qingxin
    Yang, Yanqiu
    He, Rong
    Yu, Bin
    Zhong, Yueling
    Lin, Fei
    FRONTIERS IN MEDICINE, 2023, 10
  • [9] Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
    Bhowmick, Tanaya
    Weinstein, Melvin P.
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (04) : 757 - 767
  • [10] Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
    Tanaya Bhowmick
    Melvin P. Weinstein
    Infectious Diseases and Therapy, 2020, 9 : 757 - 767
12